Talk:Thomas Okarma

From Wikipedia, the free encyclopedia

This article is within the scope of WikiProject Biography. For more information, visit the project page.
Stub This article has been rated as Stub-Class on the project's quality scale. [FAQ]
This article has been automatically assessed as Stub-Class by WikiProject Biography because it uses a stub template.
  • If you agree with the assessment, please remove {{WPBiography}}'s auto=yes parameter from this talk page.
  • If you disagree with the assessment, please change it by editing the class parameter of the {{WPBiography}} template, removing {{WPBiography}}'s auto=yes parameter from this talk page, and removing the stub template from the article.
WikiProject Dartmouth College This article is within the scope of WikiProject Dartmouth College, which collaborates on articles related to Dartmouth College.
Stub This article has been rated as Stub-Class on the assessment scale.
No This article is on a subject of no importance within WikiProject Dartmouth College.

This article has been rated but has no comments. If appropriate, please review the article and leave comments here to identify the strengths and weaknesses of the article and what work it will need.


Proposed merger with Geron Corp.

I am against merging the Thomas Okarma page with the Geron Corporation page. Thomas Okarma has been the CEO of other companies besides Geron and has been participated in Congressional hearings regarding embryonic stem cells and cloning, which are important issues that extend far beyond just Geron Corportaion.--Biotech1 05:02, 15 August 2007 (UTC).


Thomas Okarma does not seem to be a scientist of note.

The 2006 Lasker prize for basic medical sciences was awarded to Elizabeth Blackburn, Carol Grieder and Jack W. Szostak, for work their on telomeres and telomerase. No mention was made of anybody at "Geron Corp."